TAILΦR (Tailored Antibacterials and Innovative Laboratories for phage (Φ) Research) Labs at Baylor College of Medicine, delivers personalized and effective treatments for challenging antibiotic-resistant bacterial infections by cultivating scientific and medical expertise, technology, and innovation to generate an expedited bench-to-bedside pipeline. They TAILOR infection and biocontrol for healthcare, animal care, agricultural and industrial settings.
TAILΦR provides personalized solutions for infectious disease and industrial biocontrol and develops new technologies that facilitate the discovery and evolution of novel phages with enhanced attributes for your unique applications. Through these efforts, they will compile the largest characterized library of therapeutic phages for all major drug-resistant bacterial species. TAILΦR aims to kick-start an adaptable medicine revolution, wielding the same weapon that empowers diseases to resist traditional treatments: directed change.
TAILΦR is a non-profit initiative providing at-cost services designed to help the most pressing medical and industrial needs that are threatened by bacterial infection or contamination. The TAILΦR team strives to provide:
- Safe, targeted antibacterial products that are thoroughly characterized and documented.
- Quantitative and reproducible results that can be trusted and verified.
- Transparent collaborations with a team-like culture that meet the specific needs the project requires.
Phage therapy in the US is currently only available for compassionate use. You can find out more information on compassionate use in the US here.